Back to News
Market Impact: 0.45
Why Is Moderna Stock Sinking Thursday?
Source: benzinga.com
Healthcare & BiotechCompany Fundamentals
Moderna shares plunged more than 25% on Thursday after an alleged leak of an ESMO 2026 conference abstract raised concerns about the effectiveness of its experimental personalized melanoma vaccine.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
MRNA-0.80
More News
- Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
- Moderna shares plunge after leak of partial cancer vaccine data
- Moderna's stock tumbles after reported leak of data for cancer vaccine
- Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data
- Why Moderna stock plunged despite positive cancer vaccine trail results?
- Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports